David A Montecalvo's Net Worth
$6.19 Million
Who is David A Montecalvo?
David A Montecalvo has an estimated net worth of $6.19 Million. This is based on reported shares across multiple companies, which include WEST PHARMACEUTICAL SERVICES INC, and UROLOGIX INC.
SEC CIK
David A Montecalvo's CIK is 0001241973
Past Insider Trading and Trends
2020 was David A Montecalvo's most active year for acquiring shares with 6 total transactions. David A Montecalvo's most active month to acquire stocks was the month of January. 2020 was David A Montecalvo's most active year for disposing of shares, totalling 9 transactions. David A Montecalvo's most active month to dispose stocks was the month of June. 2018 saw David A Montecalvo paying a total of $1,833,359.28 for 20,438 shares, this is the most they've acquired in one year. In 2020 David A Montecalvo cashed out on 36,931 shares for a total of $4,728,060.55, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
WEST PHARMACEUTICAL SERVICES INC (WST) Snapshot price: $412.69
SVP, Glob Ops and Supply Chain
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +35.49% | 3.6K |
$369.13 | $1,327,760.61 | 13.73K |
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
| -0.27% | -27.00 |
$391.20 | -$10,562.40 | 10.13K |
Feb 13
| |||
Form 4
| -5.75% | -620.00 |
$457.11 | -$283,408.20 | 10.16K |
Sep 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
| +71.12% | 4.48K |
$272.65 | $1,221,744.65 | 10.78K |
Feb 22
| |||
Form 4
| -0.14% | -9.00 |
$294.01 | -$2,646.09 | 6.3K |
Feb 14
| |||
Form 4
| +27.71% | 1.37K |
$171.40 | -$3,255,660.60 | 6.31K |
Jul 28 - Jul 29
| |||
Form 4
| +8.17% | 373 |
$156.49 | $58,370.77 | 4.94K |
Mar 2
| |||
Form 4
| +45.07% | 1.42K |
$173.22 | $245,799.18 | 4.57K |
Feb 18
| |||
Form 4
| +20.06% | 526 |
$106.14 | $55,829.64 | 3.15K |
Mar 1
| |||
Form 4
| +37.56% | 716 |
$102.51 | $73,397.16 | 2.62K |
Feb 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 20
| |||
Form 4
| +25.39% | 386 |
$93.00 | $35,898.00 | 1.91K |
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
| +8.96% | 125 |
$86.93 | $10,866.25 | 1.52K |
Feb 14
| |||
Form 4
|
∞
| 1.39K |
—
|
—
| 1.39K |
Sep 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
UROLOGIX INC No price found
VP, Product Dev. & Operations
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||